# Hydrogen improves the efficacy of tetrandrine in the treatment of silicosis by inhibiting vascular endothelial mesenchymal transition caused by oxidative stress

**Authors:** Kang Xiao, Ming Li, Yingwen Mu, Yuxin Sun, Sirui Wang, Shangya Chen, Jiazi Ma, Mao Cao, Yong Yang, Hua Shao, Xuansheng Ding, Guanqun Cui, Zhongjun Du

PMC · DOI: 10.3389/fbioe.2025.1668524 · Frontiers in Bioengineering and Biotechnology · 2026-01-05

## TL;DR

Hydrogen improves tetrandrine's effectiveness in treating silicosis by reducing oxidative stress and endothelial cell changes in the lungs.

## Contribution

This study reveals that hydrogen enhances tetrandrine's efficacy by inhibiting oxidative stress-induced EndMT in silicosis.

## Key findings

- Silicosis causes oxidative stress and EndMT, reducing tetrandrine concentration in lung tissue.
- Hydrogen inhalation increases tetrandrine levels and reduces silicosis severity in mice.
- Hydrogen inhibits APP release and its interaction with CD74, preventing EndMT and vascular stenosis.

## Abstract

Silicosis, a lung disease associated with occupational exposure. Tetrandrine has been approved for the treatment of silicosis in China, but it still cannot be cured. This study aims to investigate the reasons behind the low concentration of tetrandrine (Tet) in lung tissue and propose a treatment plan.

We first established a silicosis mouse and employed a combination of histological examination, Western blot analysis, immunofluorescence, and single-cell RNA sequencing to clarify the relationship between oxidative stress vascular endothelial mesenchymal transition (EndMT), and Tet concentration in lung tissue.

The study indicated that there is excessive activation of OS and EndMT in silicosis while concurrently reducing Tet concentration in lung tissue (from 94.8 ± 10.4 ng/mg to 54 ± 6.2 ng/mg). Furthermore, combined inhalation of hydrogen (H2) improved both the severity of silicosis and Tet concentration in lung tissue (from 50 ng/mg to 80 ng/mg). The proposed mechanism suggests that H2 inhibits the release of amyloid precursor protein (APP) in apoptotic alveolar macrophages. Additionally, the interaction between APP and CD74 in vascular endothelial cells was diminished, thereby inhibiting biological processes associated with endothelial mesenchymal transition, alleviating pulmonary vascular stenosis, and enhancing the concentration of therapeutic agents in lung tissue.

Hydrogen can improve the tissue concentration of tetrandrine by anti-OS-induced EndMT.

Graphical summary illustrating endothelial to mesenchymal transition (EndMT) in normal and silicosis conditions. On the left, a macrophage and endothelial cells under normal conditions are shown. The right side depicts silicosis with macrophage interaction and signaling pathways involving ROS, mitophagy, apoptosis, and EndMT, leading to pathological changes.

## Linked entities

- **Proteins:** CD74 (CD74 molecule)
- **Chemicals:** tetrandrine (PubChem CID 73078), hydrogen (PubChem CID 783)
- **Diseases:** silicosis (MONDO:0005960)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** App (amyloid beta precursor protein) [NCBI Gene 11820] {aka Abeta, Abpp, Adap, Ag, Cvap, E030013M08Rik}, Cd74 (CD74 antigen (invariant polypeptide of major histocompatibility complex, class II antigen-associated)) [NCBI Gene 16149] {aka CLIP, DHLAG, HLADG, Ia-GAMMA, Ii}
- **Diseases:** lung disease (MESH:D008171), OS (MESH:C567932), pulmonary vascular stenosis (MESH:D011666), Silicosis (MESH:D012829)
- **Chemicals:** H2 (MESH:D006859), Tet (MESH:C009438)
- **Species:** Mus musculus (house mouse, species) [taxon 10090]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12813091/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12813091/full.md

## References

38 references — full list in the complete paper: https://tomesphere.com/paper/PMC12813091/full.md

---
Source: https://tomesphere.com/paper/PMC12813091